Skip to main content
HHS Logo U.S. Department of Health & Human Services Divider arrow NIH logo National Institutes of Health Alt desc

Work with Us

NCATS' combination screening platform experts regularly collaborate with basic researchers and clinical investigators inside and outside the National Institutes of Health on an as-needed basis.

Contact Nicole Spears

Matrix Combination Screening

NCATS experts use a technology called matrix combination screening to quickly narrow down a long list of potential drug combinations and find those with the most potential to help patients. Learn more.

Find NCATS Programs & InitiativesAccess NCATS Expertise & Resources

About Matrix Combination Screening

Find out more about matrix combination screening and the goals for this work at NCATS.

Scientific Capabilities

Discover details about the robotic combination screening platform that forms the foundation of this innovative approach.

Work with Matrix Screening

Find out how basic researchers and clinical investigators can collaborate with NCATS experts for matrix screening.

Matrix Screening Projects

Explore the details behind current Matrix Screening program projects.

A New Way to Test Promising Drug Combinations

Often, current medical treatments for a variety of diseases — including cancer, tuberculosis and brain disorders — involve administering more than just one drug, an approach known as combination therapy. Thousands of approved and investigational drugs can be combined in millions of possible pairings and dose variations. Clinicians often must make decisions based on trial and error, which is not optimal for the patient or the clinician. Learn more about how NCATS is addressing this critical challenge.